Company intelligence / Profile preview

MedMind Technology Co., Ltd

China
Ownership
Private
Development stage
Other
01

Overview

Company develops AI-driven software for intelligent analysis of large medical imaging datasets and automation of radiotherapy workflows, with products installed in over 360 hospitals globally. Their clinical research has been published in top international journals, and their RT-Mind-AI platform is FDA-cleared in the US.[1]

Therapeutic areas
Oncology
Modalities
DeviceAI-driven softwareNon-pharmacological therapy
Industry
Digital Health Medical Devices

Beyond the preview

Go deeper on MedMind Technology Co., Ltd.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MedMind Technology Co., Ltd.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call